U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Bradley LA, Palomaki G, Gutman S, et al. PCA3 Testing for the Diagnosis and Management of Prostate Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. (Comparative Effectiveness Reviews, No. 98.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of PCA3 Testing for the Diagnosis and Management of Prostate Cancer

PCA3 Testing for the Diagnosis and Management of Prostate Cancer [Internet].

Show details

Appendix CSearch Strategy for Grey Literature

Regulatory Information

Clinical trial registries

  • NIH database
    Date searched: 5/15/2012
    Search strategy: PCA3 [ALL-FIELDS] AND “Completed” [OVERALL-STATUS]
    Records: 6
  • BioMed central
    Date searched: 8/15/2011
    Search strategy: “PCA3” for completed trials
    Records: 0
  • WHO International Clinical Trials Registry Platform Search Portal
    Date searched: 8/15/2011
    Search strategy: Search String = “PCA3” for ALL recruitment status trials
    Records: 0

Conference papers and abstracts

Organizations publishing Guidance or Review Documents

  • Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • Australia and New Zealand Horizon Scanning Network (ANZHSN)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • Canadian Agency for Drugs and Technologies in Health (CADTH)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 3 (all excluded; not relevant)
  • The Cochrane Collaboration (Cochrane)
    Date searched: 8/15/2011
    Search strategy: search string string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR“differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • European network for Health Technology Assessment (EUnetHTA)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • EuroGenTest
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • National Guideline Clearinghouse (NGC)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”). – searches done in different combinations using the above combinations.
    Records: 4
  • National Institute for Clinical Excellence (NICE)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 1 (excluded; not relevant)
  • United Kingdom Health Technology Assessment Programme (UK HTA)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 7

Government documents

Manufacturer database

  • Source: GenProbe Response to the Request for Scientific Information
    Date posted: 12/7/2011
    Date searched: Not applicable
    Search strategy: Not applicable
    Records: 27

References for Review and Abstraction from the Grey Literature Search

PUBMED ID: NA

Authors: Submitted by Gen-Probe, Inc.

Title: Summary of Safety and Effectiveness Data: PROGENSA PCA3 Assay.

Citation: U.S. Food and Drug Administration, http://www.accessdata.fda.gov/cdrh_docs/pdf10/P100033b.pdf, accessed June 1, 2012.

Selected Test Manufacturers for Contact

ManufacturerRegistered® / Trademark Name™Test TypeComment
GenProbeGen-Probe
PROGENSA PCA3
FDA Approval announced 2/17/12Responded pre-FDA approval
Quest DiagnosticsPCA3 Diagnostic TestLDTDid not respond
Bostwick LaboratoriesPCA3Plus®LDTDid not respond
Laboratory Corporation of AmericaCaPDetect: PCA3LDTDid not respond

Contact Information

Gen Probe Incorporated10210 Genetic Center Drive
San Deigo, CA 92121
Phone: 858-410-8000
http://www​.genprobe.com
Quest Diagnostics3 Giralda Farms
Madison, NJ 07940
Phone: 800-222-0446
http://www​.questdiagnostics.com
Bostwick Laboratories4355 Innslake Drive
Glen Allen, VA 23060
Phone: 877-865-3262
http://www​.bostwicklaboratories.com
Laboratory Corporation of America358 South Main Street
Burlington, NC 27215
Phone: 336-584-5171
http://www​.labcorp.com

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.8M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...